DrugPatentWatch Database Preview

Daiichi Sankyo Company Profile

DAIICHI SANKYO has eleven approved drugs.

There are four US patents protecting DAIICHI SANKYO drugs.

There are one hundred and seventy-four patent family members on DAIICHI SANKYO drugs in thirty-four countries and forty-six supplementary protection certificates in fourteen countries.

International Patents:	174
US Patents:	4
Tradenames:	9
Ingredients:	9
NDAs:	11
Patent Litigation for Daiichi Sankyo:	See patent lawsuits for Daiichi Sankyo
PTAB Cases with Daiichi Sankyo as patent owner:	See PTAB cases with Daiichi Sankyo as patent owner

Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Daiichi Sankyo Inc	MORPHABOND ER	morphine sulfate	TABLET, EXTENDED RELEASE;ORAL	206544-002	Oct 2, 2015		RX	Yes	No	7,955,619	➤ Sign Up	Y			➤ Sign Up
Daiichi Sankyo	TRIBENZOR	amlodipine besylate; hydrochlorothiazide; olmesartan medoxomil	TABLET;ORAL	200175-005	Jul 23, 2010	AB	RX	Yes	Yes		➤ Sign Up				➤ Sign Up
Daiichi Sankyo	BENICAR HCT	hydrochlorothiazide; olmesartan medoxomil	TABLET;ORAL	021532-005	Jun 5, 2003	AB	RX	Yes	Yes		➤ Sign Up				➤ Sign Up
Daiichi Sankyo Inc	SAVAYSA	edoxaban tosylate	TABLET;ORAL	206316-003	Jan 8, 2015		RX	Yes	Yes	9,149,532	➤ Sign Up	Y			➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Daiichi Sankyo	WELCHOL	colesevelam hydrochloride	TABLET;ORAL	021176-001	May 26, 2000	5,917,007*PED	➤ Sign Up
Daiichi Sankyo Inc	EVOXAC	cevimeline hydrochloride	CAPSULE;ORAL	020989-002	Jan 11, 2000	5,580,880	➤ Sign Up
Daiichi Sankyo	TRIBENZOR	amlodipine besylate; hydrochlorothiazide; olmesartan medoxomil	TABLET;ORAL	200175-003	Jul 23, 2010	5,616,599*PED	➤ Sign Up
Daiichi Sankyo	WELCHOL	colesevelam hydrochloride	FOR SUSPENSION;ORAL	022362-002	Oct 2, 2009	6,433,026*PED	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Tablets	625 mg	➤ Subscribe	2009-07-01
➤ Subscribe	Tablets	5 mg/20 mg and 10 mg/40 mg	➤ Subscribe	2008-02-11
➤ Subscribe	Tablets	5 mg, 20 mg and 40 mg	➤ Subscribe	2006-04-25
➤ Subscribe	Tablets	40 mg/12.5 mg and 40 mg/25 mL	➤ Subscribe	2007-02-15
➤ Subscribe	Tablets	15 mg, 30 mg, 60 mg and 100 mg	➤ Subscribe	2019-01-28
➤ Subscribe	Powder for Oral Suspension	1.875 g/Packet and 3.75 g/Packet	➤ Subscribe	2010-04-09
➤ Subscribe	Tablets	10 mg/20 mg and 5 mg/40 mg	➤ Subscribe	2008-03-31
➤ Subscribe	Tablets	20 mg/12.5 mg	➤ Subscribe	2007-05-11
➤ Subscribe	Capsules	30 mg	➤ Subscribe	2009-02-27
➤ Subscribe	Tablets	15 mg, 30 mg and 60 mg	➤ Subscribe	2019-01-28

Subscribe to access the full database, or try a Free Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2140867	PA2018005,C2140867	Lithuania	➤ Sign Up	PRODUCT NAME: EDOKSABANAS, JO FARMACINIU POZIURIU PRIIMTINA DRUSKA, ARBA BET KURIO IS JU HIDRATAS, YPAC EDOKSABANO P-TOLUENSULFONATO MONOHIDRATAS; REGISTRATION NO/DATE: EU/1/15/993/001-028 20150619
1003503	05C0048	France	➤ Sign Up	PRODUCT NAME: AMLODIPINE OU UN DE SES SELS D?ADDITION D?ACIDES PHARMACAUTIQUEMENT ACCEPTABLES/ ATORVASTATINE OU UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLES; REGISTRATION NO/DATE IN FRANCE: NL 29929 DU 20050707; REGISTRATION NO/DATE AT EEC: NL 29929 DU 20050707
0503785	C300375	Netherlands	➤ Sign Up	PRODUCT NAME: COMBINATIE VAN OLMESARTAN MEDOXOMIL, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT EN AMLODIPINEBESILAAT; REGISTRATION NO/DATE: RVG100984, RVG100986-87, RVG100989-91, RVG100993-95 20080819
0503785	91330	Luxembourg	➤ Sign Up	CERTIFICATE TITLE: UNE COMBINAISON D'OLMESARTAN MEDOXOMIL, OPTIONNELLEMENT SOUS LA FORME D'UN SEL PHARMACEUTIQUEMENT ACCEPTABLE ET D'HYDROCHLOROTHIAZIDE (OLMETEC PLUS)
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.